tiprankstipranks
Trending News
More News >
Armata Pharmaceuticals Inc (ARMP)
:ARMP
US Market

Armata Pharmaceuticals (ARMP) Income Statement

Compare
270 Followers

Armata Pharmaceuticals Income Statement

Last quarter (Q1 2025), Armata Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Armata Pharmaceuticals's net income was $-6.53M. See Armata Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.17M$ 4.53M$ 5.51M$ 4.47M$ 823.00K
Gross Profit
$ 3.85M$ -29.24M$ 4.62M$ -15.54M$ -13.62M
Operating Expenses
$ 47.61M$ 11.65M$ 36.95M$ 8.28M$ 7.97M
Depreciation and Amortization
$ 1.32M$ 972.00K$ 892.00K$ 1.17M$ 1.11M
EBITDA
$ -6.85M$ -39.92M$ -36.05M$ -22.65M$ -20.44M
Operating Income
$ -42.44M$ -40.89M$ -36.95M$ -23.82M$ -21.59M
Other Income/Expenses
$ 23.52M$ -28.16M$ 29.00K$ 667.00K$ -594.00K
Pretax Income
$ -18.92M$ -69.05M$ -36.92M$ -23.16M$ -22.18M
Net Income
$ -18.92M$ -69.05M$ -36.92M$ -23.16M$ -22.18M
Per Share Metrics
Basic EPS
$ -0.52$ -1.91$ -1.08$ -0.96$ -1.35
Diluted EPS
$ -0.32$ -1.91$ -1.08$ -0.96$ -1.35
Weighted Average Shares Outstanding
36.16M 36.08M 34.29M 24.10M 16.41M
Weighted Average Shares Outstanding (Diluted)
59.06M 36.08M 34.29M 24.10M 16.41M
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis